Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 906726, 10 pages
http://dx.doi.org/10.1155/2013/906726
Research Article

Brazilian Green Propolis Suppresses the Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia

1Department of Aging Science and Pharmacology, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
2Institution of Geriatric Qinghai Provincial Hospital, Xining 810007, China

Received 27 February 2013; Revised 17 June 2013; Accepted 2 July 2013

Academic Editor: Nilanjana Maulik

Copyright © 2013 Zhou Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. W. Carlson, J. R. Carlson, V. J. Neelon, and M. Hartman, “Tailoring protocols to successfully recruit and retain older adults in a longitudinal study of sleep and cognition,” Research in Gerontological Nursing, vol. 1, no. 4, pp. 232–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. G. W. Kreutzberg, “Microglia: a sensor for pathological events in the CNS,” Trends in Neurosciences, vol. 19, no. 8, pp. 312–318, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. W. J. Streit, J. R. Conde, S. E. Fendrick, B. E. Flanary, and C. L. Mariani, “Role of microglia in the central nervous system's immune response,” Neurological Research, vol. 27, no. 7, pp. 685–691, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Kaur, V. Sivakumar, Z. Zou, and E. A. Ling, “Microglia-derived proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta induce Purkinje neuronal apoptosis via their receptors in hypoxic neonatal rat brain,” Brain Structure & Function. In press.
  5. S. Carloni, E. Mazzoni, M. Cimino et al., “Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat,” Neurobiology of Disease, vol. 21, no. 1, pp. 119–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Deng, J. Lu, V. Sivakumar, E. A. Ling, and C. Kaur, “Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway in hypoxic neonatal rats,” Brain Pathology, vol. 18, no. 3, pp. 387–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Sivakumar, W. S. Foulds, C. D. Luu, E.-A. Ling, and C. Kaur, “Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina,” The Journal of Pathology, vol. 224, no. 2, pp. 245–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. T. Heneka, M. K. O'Banion, D. Terwel, and M. P. Kummer, “Neuroinflammatory processes in Alzheimer's disease,” Journal of Neural Transmission, vol. 117, no. 8, pp. 919–947, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. L. McGeer, J. Rogers, and E. G. McGeer, “Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years,” The Journal of Alzheimer's Disease, vol. 9, no. 3, pp. 271–276, 2006. View at Google Scholar · View at Scopus
  10. H. Nakanishi and Z. Wu, “Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging,” Behavioural Brain Research, vol. 201, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Kaur and E. A. Ling, “Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells,” Progress in Neurobiology, vol. 87, no. 4, pp. 264–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Kaur, V. Sivakumar, G. W. Yip, and E. A. Ling, “Expression of syndecan-2 in the amoeboid microglial cells and its involvement in inflammation in the hypoxic developing brain,” Glia, vol. 57, no. 3, pp. 336–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Rathnasamy, E.-A. Ling, and C. Kaur, “Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen/nitrogen species,” The Journal of Neuroscience, vol. 31, no. 49, pp. 17982–17995, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Yao, E. M. Kan, J. Lu et al., “Toll-like receptor 4 (TLR4) mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia,” Journal of Neuroinflammation, vol. 10, p. 23, 2013. View at Publisher · View at Google Scholar
  15. V. S. Bankova, S. L. De Castro, and M. C. Marcucci, “Propolis: Recent advances in chemistry and plant origin,” Apidologie, vol. 31, no. 1, pp. 3–15, 2000. View at Google Scholar · View at Scopus
  16. M. Marcucci, “Propolis: chemical composition, biological properties and therapeutic activity,” Apidologie, vol. 26, no. 2, pp. 83–99, 1995. View at Google Scholar · View at Scopus
  17. G. A. Burdock, “Review of the biological properties and toxicity of bee propolis (propolis),” Food and Chemical Toxicology, vol. 36, no. 4, pp. 347–363, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Banskota, Y. Tezuka, and S. Kadota, “Recent progress in pharmacological research of propolis,” Phytotherapy Research, vol. 15, no. 7, pp. 561–571, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Sforcin, “Propolis and the immune system: a review,” Journal of Ethnopharmacology, vol. 113, no. 1, pp. 1–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. F. N. Ramos and J. L. De Miranda, “Propolis: a review of its anti-inflammatory and healing actions,” Journal of Venomous Animals and Toxins Including Tropical Diseases, vol. 13, no. 4, pp. 697–700, 2007. View at Google Scholar · View at Scopus
  21. K. Nakamichi, M. Saiki, H. Kitani et al., “Suppressive effect of simvastatin on interferon-β-induced expression of CC chemokine ligand 5 in microglia,” Neuroscience Letters, vol. 407, no. 3, pp. 205–210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Takenouchi, K. Ogihara, M. Sato, and H. Kitani, “Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line,” Biochimica et Biophysica Acta, vol. 1726, no. 2, pp. 177–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Wu, J. Zhang, and H. Nakanishi, “Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation,” Journal of Neuroimmunology, vol. 167, no. 1-2, pp. 90–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Wu, Y. Tokuda, X.-W. Zhang, and H. Nakanishi, “Age-dependent responses of glial cells and leptomeninges during systemic inflammation,” Neurobiology of Disease, vol. 32, no. 3, pp. 543–551, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Robinson, M. S. Janes, M. Pehar et al., “Selective fluorescent imaging of superoxide in vivo using ethidium-based probes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 41, pp. 15038–15043, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Hayashi, M. Yoshida, M. Yamato et al., “Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor A in mice,” Journal of Neuroscience, vol. 28, no. 34, pp. 8624–8634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Nakanishi, Y. Hayashi, and Z. Wu, “The role of microglial mtDNA damage in age-dependent prolonged LPS-induced sickness behavior,” Neuron Glia Biology, vol. 7, no. 1, pp. 17–23, 2011. View at Google Scholar
  28. S. F. Liu and A. B. Malik, “NF-κB activation as a pathological mechanism of septic shock and inflammation,” American Journal of Physiology, vol. 290, no. 4, pp. L622–L645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. B. Toledano and W. J. Leonard, “Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 10, pp. 4328–4332, 1991. View at Google Scholar · View at Scopus
  30. E. W. Englander, Z. Hu, A. Sharma, H.-M. Lee, Z.-H. Wu, and G. H. Greeley, “Rat MYH, a glycosylase for repair of oxidatively damaged DNA, has brain-specific isoforms that localize to neuronal mitochondria,” Journal of Neurochemistry, vol. 83, no. 6, pp. 1471–1480, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Sforcin and V. Bankova, “Propolis: is there a potential for the development of new drugs?” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 253–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. J. Rossi, J. D. Brady, and C. Mohr, “Astrocyte metabolism and signaling during brain ischemia,” Nature Neuroscience, vol. 10, no. 11, pp. 1377–1386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. E. Lakhan, A. Kirchgessner, and M. Hofer, “Inflammatory mechanisms in ischemic stroke: therapeutic approaches,” Journal of Translational Medicine, vol. 7, article 97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Nurmi, P. J. Lindsberg, M. Koistinaho et al., “Nuclear factor-κB contributes to infarction after permanent focal ischemia,” Stroke, vol. 35, no. 4, pp. 987–991, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. Z.-H. Qin, L.-Y. Tao, and X. Chen, “Dual roles of NF-κB in cell survival and implications of NF-κB inhibitors in neuroprotective therapy,” Acta Pharmacologica Sinica, vol. 28, no. 12, pp. 1859–1872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Gerhard, B. Neumaier, E. Elitok et al., “In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke,” NeuroReport, vol. 11, no. 13, pp. 2957–2960, 2000. View at Google Scholar · View at Scopus
  37. C. J. S. Price, D. Wang, D. K. Menon et al., “Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke,” Stroke, vol. 37, no. 7, pp. 1749–1753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Zawadzka, M. Dabrowski, A. Gozdz et al., “Early steps of microglial activation are directly affected by neuroprotectant FK506 in both in vitro inflammation and in rat model of stroke,” Journal of Molecular Medicine, vol. 90, no. 12, pp. 1459–1471, 2012. View at Publisher · View at Google Scholar
  39. T. F. Hornbein, “Long term effects of high altitude on brain function,” International Journal of Sports Medicine, vol. 13, no. 1, pp. S43–S45, 1992. View at Google Scholar · View at Scopus
  40. T. O. Nelson, J. Dunlosky, D. M. White, J. Steinberg, B. D. Townes, and D. Anderson, “Cognition and metacognition at extreme altitudes on mount everest,” Journal of Experimental Psychology, vol. 119, no. 4, pp. 367–374, 1990. View at Google Scholar · View at Scopus
  41. A. Q. Zhu, C. Y. Song, L. Y. Yang et al., “EEG and CT changes in Alzheimer's patients living at high altitude,” Clinical Focus, vol. 22, no. 17, pp. 1313–1314, 2002. View at Google Scholar
  42. E. Chleide, J. Bruhwyler, and M. Mercier, “Effect of chronic hypoxic treatment on the retention of fixed-interval responding,” Physiology and Behavior, vol. 49, no. 3, pp. 465–470, 1991. View at Publisher · View at Google Scholar · View at Scopus
  43. M. E. Raichle and M. A. Mintun, “Brain work and brain imaging,” Annual Review of Neuroscience, vol. 29, pp. 449–476, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Larsson, I. Skoog, O. Aevarsson et al., “Regional cerebral blood flow in normal individuals aged 40, 75 and 88 years studied by99Tcm-d,l-HMPAO SPET,” Nuclear Medicine Communications, vol. 22, no. 7, pp. 741–746, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. A. E. Roher, J. P. Debbins, M. Malek-Ahmadi et al., “Cerebral blood flow in Alzheimer's disease,” Vascular Health and Risk Management, vol. 8, pp. 599–611, 2012. View at Google Scholar
  46. B. W. Carlson, V. J. Neelon, J. R. Carlson, M. Hartman, and D. L. Bliwise, “Cerebral oxygenation in wake and during sleep and its relationship to cognitive function in community-dwelling older adults without sleep disordered breathing,” The Journals of Gerontology A, vol. 66, no. 1, pp. 150–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Peers, M. L. Dallas, H. E. Boycott, J. L. Scragg, H. A. Pearson, and J. P. Boyle, “Hypoxia and neurodegeneration,” Annals of the New York Academy of Sciences, vol. 1177, pp. 169–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Gao, S. Tian, H. Gao, and Y. Xu, “Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice,” Journal of Molecular Neuroscience. In press.
  49. X. Liu, Z. Wu, Y. Hayashi, and H. Nakanishi, “Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation,” Neuroscience, vol. 216, pp. 133–142, 2012. View at Google Scholar